Cargando…
Factors influencing estimated effectiveness of COVID-19 vaccines in non-randomised studies
Non-randomised studies assessing COVID-19 vaccine effectiveness need to consider multiple factors that may generate spurious estimates due to bias or genuinely modify effectiveness. These include pre-existing immunity, vaccination misclassification, exposure differences, testing, disease risk factor...
Autor principal: | Ioannidis, John P A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691814/ https://www.ncbi.nlm.nih.gov/pubmed/35338091 http://dx.doi.org/10.1136/bmjebm-2021-111901 |
Ejemplares similares
-
Postmarketing studies: can they provide a safety net for COVID-19 vaccines in the UK?
por: Dhanda, Sandeep, et al.
Publicado: (2022) -
COVID-19 and the US response: accelerating health inequities
por: Okonkwo, Nneoma E, et al.
Publicado: (2021) -
EMA’s mishandling of an investigation into suspected serious neurological harms of HPV vaccines
por: Gøtzsche, Peter C, et al.
Publicado: (2022) -
Clinical practice guideline adaptation methods in resource-constrained settings: four case studies from South Africa
por: McCaul, Michael, et al.
Publicado: (2020) -
Are CAR-T therapies living up to their hype? A study using real-world data in two cohorts to determine how well they are actually working in practice compared with bone marrow transplants
por: Schulthess, Duane, et al.
Publicado: (2021)